Specialty

Metastatic hormone-sensitive prostate cancer patients administered ADT plus enzalutamide demonstrated significantly prolonged survival. Enzalutamide adjunctive to androgen deprivation therapy (ADT) has been approved for treating metastatic hormone-sensitive prostate cancer (mHSPC) based on the clinical benefits in the ARCHES Trial Phase III. Enzalutamide with ADT, during primary analysis, reduced the risk of radiographic disease progression and...

Systemic alterations brought on by exercise can potentially decrease disease progression in men with advanced prostate cancer. Physical activity has been shown to improve physical function and the results of supportive treatment for cancer patients, particularly those with advanced disease. In addition, prostate cancer patient epidemiological studies consistently demonstrate a positive correlation between increased physical...

The electronic nose is a promising diagnostic tool with high accuracy for the identification of prostate cancer in urine samples. The gold standard for the diagnosis of prostate cancer is the prostate biopsy, with a detection rate of 21.0%–48.5% for any prostate cancer. Prostate biopsy is associated with a high rate of missed diagnoses of...

Decision-making in localized prostate cancer treatments is informed by functional and QoL outcomes over six years, without any adverse outcomes on mental and physical QoL. Radical localized prostate cancer treatments have positive oncological outcomes. Quality of life (QoL) and functional outcomes are assessed using patient-reported outcome measures (PROMs). This study aimed to analyze the QoL...

Biological mechanisms associated with prostate cancer risk and obesity form the basis for the development of prevention and treatment strategies for prostate cancer. Prostate cancer is the second most common cause of cancer-related death in the United States male population. Obesity has a prevalence of 36.6% in the adult male population in the US. Obesity...

On November 17th, 2022, in our recent webcast titled “Exploring Vitiligo Treatment Options”, Dr. Brittany Oliver, a Board-Certified Dermatologist, answers questions from Dr. Pete Thomas on treatment options for Vitiligo. Dr. Brittany Oliver is an expert in Vitiligo and has knowledge of various treatment options. The webcast covered many topics surrounding treatment. To watch this...

Milk allergy overdiagnosis is complex due to studies funded by the formula industry, and this Delphi consensus study sought to describe new guidelines that don’t result in overdiagnosis. For a variety of reasons, overdiagnosis of milk allergy in young children is common throughout the world, with prescriptions for specialized formula used to feed infants with...

Asmadroid® dramatically boosted users’ asthma cognizance levels. In this digital age, future asthma self-management apps could be a valuable and engaging instructional platform for asthmatic patients, particularly the younger generations of any society. Asthma is a chronic medical disorder characterized by wheezing, intermittent shortness of breath, and chest tightness, often at night or early in...

Social support and depression of the caregiver influence medication adherence and asthma control in children. Healthcare practitioners are encouraged to consider the social position of children with asthma and provide the appropriate type of family assistance, such as diagnosing and monitoring caregivers for signs of depression, and linking them with mental health resources. Asthma is...